The FDA's Risky Drug Approvals and Transparency Concerns
TL;DR Summary
ProPublica's year-long investigation reveals that the FDA has allowed over 150 drugs from banned factories, mainly in India, into the U.S. market without routine testing or public warning, raising concerns about drug safety and oversight.
- We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market ProPublica
- Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs ProPublica
- ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs ProPublica
- FDA Takes World Tour In Recent OTC Warnings insights.citeline.com
- FDA Approved — And Ineffective Mad In America
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
97%
1,045 → 35 words
Want the full story? Read the original article
Read on ProPublica